Gain Therapeutics (GANX) PT Lowered to $16 at B.Riley
Tweet
Share
E-mailGet Alerts GANX Hot Sheet
Price: $2.12 +2.91%
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
7 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on Gain Therapeutics (NASDAQ: GANX) to $16.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Gain Therapeutics, Inc. (GANX) Tops Q2 EPS by 3c
- Toei co Ltd (9605:JP) PT Raised to JPY6,100 at Nomura/Instinet
- Workman Co Ltd (7564:JP) (WKISF) PT Lowered to JPY8,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
